The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s viral vectors and plasmid DNA market report forecasts the viral vectors and plasmid DNA market size to grow to $1.47 Billion by 2027, with a CAGR (compound annual growth rate) of more than 12%.

Learn More On The Viral Vectors And Plasmid DNA Market Report 2023 – https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Viral Vectors And Plasmid DNA Market Size Forecast
The global viral vectors and plasmid DNA market is expected to grow from $0.8 billion in 2022 to $0.91 billion in 2023 at a compound annual growth rate (CAGR) of 14.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The viral vectors & plasmid DNA market is expected to grow from $1.47 billion in 2027 at a CAGR of 12.6%.

North America held the largest viral vectors and plasmid DNA market share, and Middle East was the fastest-growing region in 2022.

Key Viral Vectors And Plasmid DNA Market Driver ­– Rise In The Global Incidence Of Cancer
According to the American cancer society 2020, an estimated 1.8 million new cancer cases diagnosed and 606,520 cancer deaths in the United States. Furthermore, in January 2022, according to the American Cancer Society, there will likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, or roughly 1,670 fatalities every day. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. The rise in the global incidence of cancer is expected to boost the demand for the viral vectors and plasmid DNA market over the coming years.

Request for A Sample Of The Global Viral Vectors And Plasmid DNA Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3245&type=smp

Key Viral Vectors And Plasmid DNA Market Trend – Addition Of Plasma DNA Manufacturing
The addition of plasma DNA manufacturing to integrate gene therapy production is a key trend gaining popularity in the viral vectors and plasmid DNA market. Major companies operating in the viral vectors and plasmid DNA market are developing innovative methods to strengthen their position in the market. For instance, in October 2022, Forge Biologics, a US-based biotechnology company, launched the plasmid DNA manufacturing process to integrate gene therapy production service. This allows for more efficient production of their AAV programs by incorporating plasmids into the manufacturing process.

Viral Vectors And Plasmid DNA Market Segment
1) By Product: Plasmid DNA, Viral Vectors
2) By Application: Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications
3) By Disease: Infectious Diseases, Genetic Disorders, Cancer, Other Diseases
4) By End User: Research Institutes, Biopharmaceutical And Pharmaceutical Companies

Viral Vectors And Plasmid DNA Market Major Players and Strategies
Major players in the viral vectors and plasmid DNA market are FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza, Cobra Biologics and Pharmaceutical Services, Brammer Bio, Cell and Gene Therapy Catapult, VGXI and MassBiologics.

In January 2020, Cognate Bioservices Inc., a US-based company skilled in cell and cell-mediated gene therapy products, acquired Cobra Biologics, which specialised in providing manufacturing services for plasmid DNA and viral vectors, for an undisclosed amount. The acquisition is expected to create a platform for the life cycle management of cell and gene therapy products. Cobra biologics is well established in the development and manufacture of a variety of viral vectors and DNA. The combined Cognate and Cobra expertise is expected to push both the businesses to a better position to respond to current and future market demand.

The Viral Vectors And Plasmid DNA Global Market Report 2023 covers regional data on viral vectors and plasmid DNA market size, viral vectors and plasmid DNA market trends and drivers, opportunities, strategies, and viral vectors and plasmid DNA market competitor analysis. The countries covered in the viral vectors and plasmid DNA market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Viral vectors refer to a tool made of a viral genome that has been converted into a plasmid-based technology, modified for safety by deleting several necessary genes, and the viral components have been separated. Whereas, Plasmid DNA refers to a tiny, circular DNA molecule that can be found in some bacteria and other tiny organisms. Physically distinct from chromosomal DNA, plasmids multiply on their own.

View More Reports Related To The Viral Vectors And Plasmid DNA Market –
Antivirals Global Market Report 2023
DNA And Gene Chip Global Market Report 2023
DNA Based Skin Care Products Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: